권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
결과 내 검색
동의어 포함
Background: Propofol is used as an induction and maintenance agent for general anesthesia but it can cause adverse
reactions like hyperlipidemia, growth of microorganisms, and pulmonary embolisms. Microemulsion propofol
was developed to avoid these side effects but incidence and severity of pain on injection is higher than with lipid
emulsion propofol. We aimed to compare the effects of sufentanil in analgesic doses for reducing the injection pain
of microemulsion propofol.
Methods: The candidates included eighty patients, 19-60 years old and ASA I-II. They were randomly classified
into four groups and pretreated with normal saline, sufentanil 0.1 μg/kg, 0.2 μg/kg or 0.3 μg/kg before injection of
microemulsion propofol. Five minutes after receiving pretreatment drug, 2 mg/kg of microemulsion propofol was
injected and VAS was recorded.
Results: There were no significant differences in the incidence of injection pain among the groups. Severity of
injection pain was significantly lower in the sufentanil 0.3 μg/kg group than normal saline and sufentanil 0.1 μg/
kg group. Significant differences in blood pressure and heart rate were observed in sufentanil groups only after
endotracheal intubation. One patient each in sufentanil 0.1 μg/kg and 0.3 μg/kg group experienced mild cough, one
from sufentanil 0.3 μg/kg group experienced dizziness and another showed signs of hypoxia. One patient each in
normal saline and sufentanil 0.1 μg/kg group showed clinical symptoms of phlebitis in the injection area.
Conclusions: Pretreatment with sufentanil 0.3 μg/kg reduced the severity of microemulsion propofol injection pain
without increasing arterial blood pressure and heart rate after endotracheal intubation.*표시는 필수 입력사항입니다.
| 전화번호 |
|---|
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내: 정기간행물실(524호) / 서가번호: 국내18
2021년 이전 정기간행물은 온라인 신청(원문 구축 자료는 원문 이용)
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.